An Adapted Anti-Ctla4 Therapeutic Aimed at Mitigating the Toxicities of Checkpoint Inhibition

Journal of Clinical Investigation - United States
doi 10.1172/jci125800
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Immune Checkpoint Inhibition by Anti-Pdcd1 (Anti-Pd1) Monoclonal Antibody Has Significant Therapeutic Activity Against Central Nervous System Lymphoma in an Immunocompetent Preclinical Model

British Journal of Haematology
Hematology
2017English

1210 Enhancing the Therapeutic Efficacy of Immune Checkpoint Inhibition and Targeted Therapy Using Anti-Tumor Antibodies in Mouse Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Combining Anti-Ctla4 With RG7787, an Immunotoxin Targeting Mesothelin, Promotes Tumor Eradication

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Immune Checkpoint Inhibitors: Navigating a New Paradigm of Treatment Toxicities

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Preparative Immunotherapy With Anti-Ox40 and Anti-Ctla4 Improves the Response to Chemotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Toxicities of Immune Checkpoint Inhibitors: Itis-Ending Adverse Reactions and More

Cureus
2020English

Inhibition of the Spindle Assembly Checkpoint Kinase MPS-1 as a Novel Therapeutic Strategy in Malignant Mesothelioma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2017English

Checkpoint Inhibition May Trigger the Rare Variant of Anti-Lad-1 IgG-Positive, Anti-Bp180 NC16A IgG-Negative Bullous Pemphigoid

Frontiers in Immunology
AllergyImmunology
2019English

Checkpoint Inhibition Before Haploidentical Transplantation in Relapsed or Refractory Hodgkin Lymphoma Patients Is Associated With Higher PFS Without Increased Toxicities

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy